Trading Signals: ALKS Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Oct. 27, 2023)(ALKERMES PLC)
| ALKS latest price $53.7000 (2.7%) ($51.8400 - $53.8500) on Fri. Dec. 1, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.46% (three month average) | RSI | 73 | Latest Price | $53.7000(2.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ALKS advances 1% a day on average for past five trading days. | Weekly Trend | ALKS advances 3.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ALKS advance at 0% a week (0% probability) IBB(32%) XBI(31%) XLV(28%) IVE(27%) VYM(27%) | Factors Impacting ALKS price | ALKS will decline at least -1.23% in a week (0% probabilities). VIXM(-14%) TLT(-11%) UUP(-9%) TIP(-4%) GLD(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.23% (StdDev 2.46%) | Hourly BBV | 0 () | Intraday Trend | 3.3% | | | |
|
5 Day Moving Average | $51.79(3.69%) | 10 Day Moving Average | $50.67(5.98%) | 20 Day Moving Average | $49.56(8.35%) | To recent high | -2.3% | To recent low | 12.6% | Market Cap | $8.54b | | | | Alkermes Plc is a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. Its products include Aristada, which is used for the treatment of schizophrenia in adults; and Vivitrol, which is an injectable medication for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification. The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland. |